Myelogenous Leukemia Completed Phase 2 Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0030998 (Myelogenous Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00133367Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusTreatment